Safety and efficacy of very low LDL-cholesterol intensive lowering: a meta-analysis and meta-regression of randomized trials.

European heart journal. Cardiovascular pharmacotherapy(2023)

引用 15|浏览14
暂无评分
摘要
This meta-analysis indicates that very low LDL-C levels on intensive lipid-lowering treatments are not associated with any adverse event and maintain a persistent reduction of cardiovascular events.
更多
查看译文
关键词
Adverse events,Lipid-lowering therapies,Major adverse cardiovascular events,Very low LDL-C
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要